p53, p54, PUVA, and counting

Journal of the American Academy of Dermatology

Volumn 41, Issue 5 I, 1999, Pages 800-801

  Gasparro, F P ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLASTOGEN; METHOXSALEN; PROTEIN P53; PSORALEN;

CANCER INCIDENCE; DISEASE PREDISPOSITION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; NOTE; PHOTOCHEMISTRY; PRIORITY JOURNAL; PSORIASIS; PUVA; SQUAMOUS CELL CARCINOMA;

EID: 0032741178     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70018-6     Document Type: Article

References (14)

1. AJ Nataraj P Wolf L Cerroni HN Ananthswamy P53 mutations in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA): relative frequency of PUVA- versus UV-signature mutations J Invest Dermatol 109 1997 238 243
2. XM Wang JM McNiff V Klump M Asgari FP Gasparro An unexpected spectrum of p53 mutations from squamous cell carcinomas in patients treated with PUVA Photochem Photobiol 66 1997 2941 2949
3. AJ Nataraj HS Black HN Ananthswamy Signature p53 mutations at DNA crosslinking sites in 8-methoxypsoralen and ultraviolet A (PUVA)-induced murine skin cancers Proc Natl Acad Sci U S A 93 1996 7961 7965
4. V Boyer E Moustacchi E Sage Sequence specificity in photoreaction of various psoralen derivatives with DNA: role in biological activity Biochemistry 27 1998 3011 3018
5. FP Gasparro B Liao PJ Foley XM Wang JM McNiff Psoralen photochemotherapy, clinical efficacy and photomutagenicity: the role of molecular epidemiology in minimizing risks Environ Mol Mutagenesis 31 1998 105 112
6. RS Stern KT Nichols LH Väkevä for the PUVA follow-up study Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA) N Engl J Med 336 1997 1041 1045
7. RS Stern LA Thibodeau RA Kleinerman Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis N Engl J Med 300 1979 809 813
8. ML Kripke Effects of methoxsalen plus near-ultraviolet radiation or mid-ultraviolet radiation on immunologic mechanisms Natl Cancer Inst Monogr 66 1984 247 251
9. P Filipe I Emerit AA Youssefl A Levy L Carnjavski J Freitas JL Cirne de Castra Oxyradical-mediated clastogenic plasma factors in psoriasis: increases in clastogenic activity after PUVA Photochem Photobiol 66 1997 497 501
10. SS Sastry Isolation and partial characterization of a novel psoralen-tyrosine photoconjugated from a photoreaction of psoralen with a natural protein Photochem Photobiol 65 1997 937 944
11. KG Spect L Kittler WR Midden A new biological target of furocoumarins: photochemical formation of covalent adducts with unsaturated fatty acids Photochem Photobiol 47 1988 537 541
12. JD Bernhard Commentary on oral methoxsalen photochemo-therapy for the treatment of psoriasis: a cooperative clinical trial: from napkin notes to notabilia J Invest Dermatol 92 suppl 1989 154s 156s
13. D Bethea B Fullmer S Syed G Seltzer J Tiano C Rischko Psoralen photobiology and photochemotherapy: 50 years of science and medicine J Dermatol Sci 19 1999 78 88
14. J Brucke A Tanew B Ortel H Hönigsmann Relative efficacy of 335 and 365 nm radiation in photochemotherapy of psoriasis Br J Dermatol 124 1991 372 374